Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CELG

Celgene (CELG)

Celgene Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CELG
DateTimeSourceHeadlineSymbolCompany
01/03/20195:21PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/20195:21PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/20195:20PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/20195:20PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/20195:18PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/20195:16PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/20195:14PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/201911:46AMDow Jones NewsBristol-Myers Squibb to Acquire Celgene for About $74 Billion--3rd UpdateNASDAQ:CELGCelgene Corporation
01/03/201911:05AMDow Jones NewsCelgene Up Over 26% After Deal Announcement -- Data TalkNASDAQ:CELGCelgene Corporation
01/03/201910:40AMDow Jones NewsBristol-Myers Adding $50 Billion in Debt in Celgene DealNASDAQ:CELGCelgene Corporation
01/03/20199:57AMDow Jones NewsBristol-Myers Squibb to Acquire Celgene for About $74 Billion--2nd UpdateNASDAQ:CELGCelgene Corporation
01/03/20199:35AMPR Newswire (US)Celgene (CELG) Alert: Johnson Fistel Investigates Proposed Sale of Celgene Corporation; Are Celgene Shareholders Getting a Fa...NASDAQ:CELGCelgene Corporation
01/03/20199:20AMDow Jones NewsBristol-Myers Squibb to Acquire Celgene for About $74 Billion--UpdateNASDAQ:CELGCelgene Corporation
01/03/20198:42AMDow Jones NewsCelgene Shares Trade Well Below Takeover Price PremarketNASDAQ:CELGCelgene Corporation
01/03/20198:16AMDow Jones NewsBristol-Myers Forecasts 2019 Earnings Above Street ViewsNASDAQ:CELGCelgene Corporation
01/03/20197:59AMDow Jones NewsCelgene Holders Could Get Another $9/Share From CVRNASDAQ:CELGCelgene Corporation
01/03/20197:58AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/20197:57AMDow Jones NewsBristol-Myers Squibb to Acquire Celgene for About $74 BillionNASDAQ:CELGCelgene Corporation
01/03/20197:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELGCelgene Corporation
01/03/20197:08AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CELGCelgene Corporation
01/03/20196:58AMBusiness WireBristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma CompanyNASDAQ:CELGCelgene Corporation
12/24/201810:44AMInvestorsHub NewsWireGNBT - The New Generex: Unlocking The ValueNASDAQ:CELGCelgene Corporation
12/20/20184:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
12/19/201810:44AMBusiness WireDie Celgene Corp. legt Ergebnisse der AUGMENT-Studie zur Prüfung von REVLIMID® in Kombination mit Rituximab (R2) bei Patien...NASDAQ:CELGCelgene Corporation
12/19/201810:24AMBusiness WireDie Celgene Corp. und Acceleron Pharma geben bei der ASH-Jahrestagung 2018 die Ergebnisse der Phase-III-Studie BELIEVE zu Lus...NASDAQ:CELGCelgene Corporation
12/19/201810:11AMBusiness WireDie Celgene Corp. und Acceleron Pharma legen Ergebnisse der Phase-III-Studie MEDALIST zur Prüfung von Luspatercept bei Patie...NASDAQ:CELGCelgene Corporation
12/18/20186:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
12/18/20186:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
12/18/20186:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
12/18/20186:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
 Showing the most relevant articles for your search:NASDAQ:CELG